Author Question: The terminated member roster shows those members a. Who have appealed second opinion denials b. ... (Read 53 times)

DelorasTo

  • Hero Member
  • *****
  • Posts: 548
The terminated member roster shows those members
 
  a. Who have appealed second opinion denials
  b. Who have died
  c. Whose coverage is being considered for renewal
  d. Whose coverage has been terminated

Question 2

Which of the following is considered a Part B benefit?
 
  a. A biannual charge.
  b. After the deductible has been satisfied, generally 80 of the approved charge will be paid.
  c. After the deductible has been satisfied, generally 50 of the approved charge will be paid.
  d. The amount charged for the Part B deductible will depend on the amount spent by the patient for payments for services.



micaelaswann

  • Sr. Member
  • ****
  • Posts: 314
Answer to Question 1

D

Answer to Question 2

B



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Thyroid conditions may make getting pregnant impossible.

Did you know?

Studies show that systolic blood pressure can be significantly lowered by taking statins. In fact, the higher the patient's baseline blood pressure, the greater the effect of statins on his or her blood pressure.

Did you know?

Anesthesia awareness is a potentially disturbing adverse effect wherein patients who have been paralyzed with muscle relaxants may awaken. They may be aware of their surroundings but unable to communicate or move. Neurologic monitoring equipment that helps to more closely check the patient's anesthesia stages is now available to avoid the occurrence of anesthesia awareness.

Did you know?

Certain chemicals, after ingestion, can be converted by the body into cyanide. Most of these chemicals have been removed from the market, but some old nail polish remover, solvents, and plastics manufacturing solutions can contain these substances.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library